Ian Nicholson is Chair of the Remuneration Committee. Ian has over 35 years’ international experience in management and transactions within the life sciences sector including as chairman of Bioventix plc, as operating partner at London-based Advent Life Sciences LLP, and 8 years as CEO of the privately held anti-fungal drug development company F2G Limited. Ian has worked extensively in licensing, mergers and acquisitions and market development in the UK, Europe and the USA.
Ian Nicholson
Latest news
-
LifeArc Pathfinder Award recipients uncover genetic cause of severe nerve condition in children
-
LifeArc and Genetic Alliance UK launch a new report calling for the acceleration of research and development (R&D) for rare diseases
-
Innovative home monitoring service aims to improve care for patients with dementia